Achieve Life Sciences, Inc.
ACHV
$2.98
-$0.18-5.70%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.72M | -12.83M | -12.36M | -12.51M | -8.46M |
| Total Depreciation and Amortization | 55.00K | 62.00K | 58.00K | 57.00K | 57.00K |
| Total Amortization of Deferred Charges | -14.00K | 14.00K | 14.00K | 9.00K | -- |
| Total Other Non-Cash Items | 3.01M | 2.32M | 1.69M | 1.90M | 1.98M |
| Change in Net Operating Assets | 595.00K | -660.00K | 1.41M | 171.00K | 1.51M |
| Cash from Operations | -9.07M | -11.09M | -9.19M | -10.37M | -4.92M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.70M | 11.35M | 11.72M | 13.27M | -46.57M |
| Cash from Investing | 6.70M | 11.35M | 11.72M | 13.27M | -46.57M |
| Total Debt Issued | -- | -- | 0.00 | 9.81M | -- |
| Total Debt Repaid | -- | -- | 0.00 | -18.11M | -- |
| Issuance of Common Stock | 41.22M | -- | 682.00K | 183.00K | -- |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | -153.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 41.22M | -- | 682.00K | -8.11M | -153.00K |
| Foreign Exchange rate Adjustments | 2.00K | -2.00K | -1.00K | 1.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.86M | 263.00K | 3.21M | -5.21M | -51.64M |